Henderson Jane sold APGE
March 25, 2026 · Form 4 insider transaction
Henderson Jane sold 2,000 shares of Apogee Therapeutics, Inc. at $85.00 per share, a transaction worth $170.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,000
Price
$85.00
Total value
$170.0K
InsiderHenderson Jane
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 25, 2026
Filing dateMarch 27, 2026
Shares owned after179,371
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 2, 2025.